Publications

Showing records 121 - 140 (of 143)

Publication: JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)

ID	Author	Year	Title	Publisher
1196343	Romanens, Michel; Ackermann, Franz; Abay, Michael; Szucs, Thomas; Schwenkglenks, Matthias	2009	Agreement of Swiss-adapted international and European guidelines for the assessment of global vascular risk and for lipid lowering interventions	Cardiovascular drugs and therapy
1194548	Dedes, Konstantin J; Matter-Walstra, Klazien; Schwenkglenks, Matthias; Pestalozzi, Bernhard C; Fink, Daniel; Brauchli, Peter; Szucs, Thomas D	2009	Bevacizumab in combination with paclitaxel for HER-2 negative metastatic breast cancer : an economic evaluation	EJC : European journal of cancer
1196875	Blank, P. R.; Schwenkglenks, M.; Szucs, T. D.	2009	Disparities in influenza vaccination coverage rates by target group in five European countries : trends over seven consecutive seasons	Infection
1193153	Blank, Patricia R; Schwenkglenks, Matthias; Szucs, Thomas D	2009	Vaccination coverage rates in eleven European countries during two consecutive influenza seasons	The journal of infection
1195769	Blank, Patricia R.; Freiburghaus, Andreas U.; Ruf, Bernhard R.; Schwenkglenks, Matthias M.; Szucs, Thomas D.	2008	Trends in influenza vaccination coverage rates in Germany over six seasons from 2001/02 to 2006/07	Medizinische Klinik
1194551	Pettengell, Ruth; Schwenkglenks, Matthias; Leonard, Robert; Bosly, André; Paridaens, Robert; Constenla, Manuel; Szucs, Thomas D; Jackisch, Christian; Impact of Neutropenia in Chemotherapy-European Study Group (INC-EU)	2008	Neutropenia occurrence and predictors of reduced chemotherapy delivery : results from the INC-EU prospective observational European neutropenia study	Supportive care in cancer
1194565	Blijlevens, Nicole; Schwenkglenks, Matthias; Bacon, Pamela; D'Addio, Alessandra; Einsele, Hermann; Maertens, Johan; Niederwieser, Dietger; Rabitsch, Werner; Roosaar, Ann; Ruutu, Tapani; Schouten, Harry; Stone, Rebecca; Vokurka, Samuel; Quinn, Barry; McCann, Shaun	2008	Prospective oral mucositis audit : oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy : european blood and marrow transplantation mucositis advisory group	Journal of clinical oncology
1195770	Kunze, Ursula	2008	Influenza vaccination coverage rates in Austria in 2006/07 - a representative cross-sectional telephone survey	Wiener medizinische Wochenschrift
1195771	Szucs, Thomas D.	2008	Influenza vaccination coverage rates in five European countries during season 2006/07 and trends over six consecutive seasons	BMC Public Health

JournalItem (Kommentare, Editorials, Rezensionen, Urteilsanmerk., etc. in einer wissensch. Zeitschr.

ID	Author	Year	Title	Publisher
4658548	Galactionova, Katya; Salari, Paola; Mattli, Renato; Rachamin, Yael; Meier, Rahel; Schwenkglenks, Matthias	2022	Correction to: Cost-Effectiveness, Burden of Disease and Budget Impact of Inclisiran: Dynamic Cohort Modelling of a Real-World Population with Cardiovascular Disease.	PharmacoEconomics
4658550	Sendi, Pedram; Schwenkglenks, Matthias	2022	Risk-Adjusted Performance Measures: A Comment on Elbasha.	PharmacoEconomics
4487599	Matter-Walstra, Klazien Wietske; Schwenkglenks, Matthia; Dedes, Konstantin J.	2017	Cost-effectiveness of palbociclib plus letrozole versus letrozole alone as a first-line treatment in women with oestrogen receptor-positive, HER2-negative, advanced breast cancer. Revised results for the Swiss health care setting	Breast cancer research and treatment
1197724	Pettengell, Ruth; Schwenkglenks, Matthias	2011	Incidence of neutropenia, chemotherapy delivery, and use of colony-stimulating factor in patients with non-Hodgkin lymphoma of different age groups	Leukemia [and] lymphoma
1197441	Romanens, Michel; Ackermann, Franz; Spence, John David; Darioli, Roger; Rodondi, Nicolas; Corti, Roberto; Noll, Georg; Schwenkglenks, Matthias; Pencina, Michael	2010	Improvement of cardiovascular risk prediction : time to review current knowledge, debates, and fundamentals on how to assess test characteristics	European Journal of Cardiovascular Prevention and Rehabilitation
1197130	Aapro, Matti; Schwenkglenks, Matthias; Lyman, Gary H; Lopez Pousa, Antonio; Lawrinson, Susan; Skacel, Tomas; Bacon, Pamela; von Minckwitz, Gunter	2010	Pegfilgrastim primary prophylaxis vs. current practice neutropenia management in elderly breast cancer patients receiving chemotherapy	Critical reviews in oncology, hematology
1197209	von Minckwitz, G; Schwenkglenks, M; Skacel, T; Lyman, G H; Pousa, A Lopez; Bacon, P; Easton, V; Aapro, M S	2009	Febrile neutropenia and related complications in breast cancer patients receiving pegfilgrastim primary prophylaxis versus current practice neutropaenia management : results from an integrated analysis	European journal of cancer
1197814	Pettengell, R; Schwenkglenks, M; Bosly, A	2008	Association of reduced relative dose intensity and survival in lymphoma patients receiving CHOP-21 chemotherapy	Annals of hematology

Publication: NewsItemPrint (Artikel in einer Tages, Wochen- oder Monatszeitschrift)

ID	Author	Year	Title	Publisher
4606302	Bill, Marc; Kaufmann, Cornel; Mäder, Beatrice; Rieder, Stefan; Schwenkglenks, Matthias; Telser, Harry	2019	Referenzpreis: Sparmassnahme auf Kosten der Patienten?	Die Volkswirtschaft

Publication: Other Publications (Forschungsberichte o. ä.)

ID	Author	Year	Title	Publisher
4658571	Twerenbold, Sibylle; Schur, Nadine; Wittwer Nina; Schneider, Cornelia; Marxer, Carole; Spöndlin, Julia; Schwenkglenks, Matthias; Meier, Christoph R	2022	Helsana-Arzneimittelreport für die Schweiz 2022
4658578	Twerenbold, Sibylle; Schur, Nadine; Zappalà,Tamino; Gut, Stephan; Stoffel, Sandro; Salari, Paola; Galactionova,Katya; Schwenkglenks, Matthias; Meier, Christoph R	2021	Helsana-Arzneimittelreport für die Schweiz 2021

Showing records 121 - 140 (of 143)